Category: by publisher

Aftermath: Gut-wrenching misstep leads to retraction, frayed feelings and a paperless postdoc

Graham Ellis-Davies says January 25th was one of the worst days of his life. That was when the journal ChemBioChem retracted an article, published barely two weeks earlier, for a mistake Ellis-Davies blames squarely on himself.

The fallout has been nearly two months of painful self-recrimination, a tattered friendship and, perhaps most significant, he adds, the wasted effort of a postdoc who poured months of research into a now worthless publication. Continue reading Aftermath: Gut-wrenching misstep leads to retraction, frayed feelings and a paperless postdoc

Tenth Bulfone-Paus retraction notice appears, in Journal of Biological Chemistry

The tenth of 12 promised retractions by Silvia Bulfone-Paus and colleagues has appeared, in the Journal of Biological Chemistry (JBC).

The paper, “Reverse signaling through membrane-bound Interleukin-15,” was published in 2004 and has been cited 31 times, according to Thomson Scientific’s Web of Knowledge. The retraction notice, just like the other one for the team’s work that appeared in the JBC, was completely uninformative: Continue reading Tenth Bulfone-Paus retraction notice appears, in Journal of Biological Chemistry

Joachim Boldt retraction tally drops by one, editors say (but record’s still safe)

As the news of Joachim Boldt’s staggering number of retractions leaps from Retraction Watch into the mainstream press, the consortium of journal editors retracting his studies has backtracked ever so slightly, announcing today that one of the 89 studies for which the German anesthesiologist lacked ethics approval in fact had such sanction.

According to the now-16 (Updated 3/7/11, as it is up from 11 several days ago) editors, LÄK-RLP,  the German body investigating the ethics component of the Boldt case: Continue reading Joachim Boldt retraction tally drops by one, editors say (but record’s still safe)

Plagiarism and other ‘negligence’ fell lung-estrogen paper

There’s parsing a-plenty in the American Journal of Physiology Lung Cellular and Molecular Physiology this month. The journal has retracted a 2010 paper by researchers at Chiba University in Japan, who lifted much of their manuscript from an article by other scientists in a different publication.

The authors of the paper, “The estrogen paradox in pulmonary arterial hypertension,” confess that they misappropriated text. But how they do so is a case study in subtlety: Continue reading Plagiarism and other ‘negligence’ fell lung-estrogen paper

Two more retractions for Mori make 16 — but not a record

Biochemical Journal has retracted two articles by Naoki Mori, bringing the total number of pulled papers by the Japanese cancer researcher to sixteen.

As with the previous Mori retractions, the latest ones — of papers published in 2007 and 2010 — involve unreliable images. Mori, you’ll recall, had recycled control blots from study to study over the years, and was dismissed from his academic post in August.

The 2007 paper, “Activation of hypoxia-inducible factor 1 in human T-cell leukaemia virus type 1-infected cell lines and primary adult T-cell leukaemia cells,” also included a frequent co-author Mariko Tomita, who has been implicated in the deception. It has been cited 15 times, according to Thomson Scientific’s Web of Knowledge. The 2010 article, “Inhibition of Akt/GSK3β signalling pathway by Legionella pneumophila is involved in induction of T-cell apoptosis,” has not yet been cited.

In each case, the retraction notice is the same: Continue reading Two more retractions for Mori make 16 — but not a record

22 papers by Joachim Boldt retracted, and 67 likely on the way

Self-plagiarism alert: A very similar version of this post is being published online in Anesthesiology News, where one of us (AM) is managing editor.

Anesthesia & Analgesia has retracted 22 papers by Joachim Boldt, the discredited German anesthesiologist whose prolific career as a researcher has unraveled with stunning rapidity — and 67 more retractions are likely on the way from 10 other titles  that have published his work.

The 22 retractions, announced Feb. 25 on the journal’s website, come less than a month after the state medical board overseeing an investigation into Boldt’s publications said that it was looking into more than 90 of his articles out of concern that he had failed to obtain proper approval from an institutional review board for the work.

The board, Landesärztekammer Rheinland-Pfalz (LÄK-RLP), investigated 102 articles. Investigators could not find evidence of adequate IRB approval for 89 papers; for the remaining, 11 had IRB approval and two did not require it, according to the A&A notice, which was signed by  editor-in-chief Steven L. Shafer: Continue reading 22 papers by Joachim Boldt retracted, and 67 likely on the way

University of Sao Paulo fires professor after a retraction for plagiarism

February has turned out to be a bad month for people found guilty of plagiarism. On Friday, we covered the case of the German foreign defense minister who lost his PhD after his university became aware he had copied passages from newspaper stories into his thesis.

And now we’ve learned that the University of Sao Paolo Paulo (USP) dismissed a full professor earlier this month after an investigation into a study he retracted last year because parts of it had been plagiarized. It has also stripped one of the professor’s former students of her PhD. Continue reading University of Sao Paulo fires professor after a retraction for plagiarism

Ninth Bulfone-Paus retraction notice appears, in Molecular and Cellular Biology

Another retraction notice for a paper published by Silvia Bulfone-Paus and colleagues has appeared, this one for a 2005 paper in Molecular and Cellular Biology.

The retraction notice is brief but to the point: Continue reading Ninth Bulfone-Paus retraction notice appears, in Molecular and Cellular Biology

Korean ENT journal retracts 17 papers, citing ‘overlap’

A Mongolian gerbil (from EdShal on flickr) http://www.flickr.com/photos/21507874@N07/2469088105

The Korean Journal of Otolaryngology-Head and Neck Surgery has retracted 17 papers, with the common theme of ‘overlap’ — almost always a euphemism for plagiarism, whether self or otherwise.

Published between 1993 and 2006, the articles came from a group of authors at the department of otolaryngology at Ajou University School of Medicine in Suwon, South Korea. Their topics range from “The Effects of Intratympanic Steroid Injection for the Patients with Refractory Sudden Sensorineural Hearing Loss” to “Study for Reversibility of Experimental Cholesteatoma Using Mongolian Gerbil.”

The retraction notices all read basically the same way. Here’s the one for the gerbil paper: Continue reading Korean ENT journal retracts 17 papers, citing ‘overlap’

More on SPIROCOR noninvasive heart disease test: Second retraction (in fact the first) says little

Since we first wrote about the travails of Spirocor’s bedside, noninvasive test for coronary artery disease, we’ve been trying, without much success, to find out more information.

But as they say about every dog, our day has come.

As we initially reported, Ron Waksman, a prominent Washington, D.C. cardiologist and editor-in-chief of Cardiovascular and Revascularization Medicine, was first author of one of two papers about the Spirocor technology that were published in 2010. The other, by Shiyovich, et al, was retracted earlier this month by the American Journal of the Medical Sciences, which triggered our interest in this case.

At the time, we couldn’t find any evidence that Waksman’s article had been retracted, and Waksman has not responded to multiple requests for comment. Today we spoke with Kate Coons, the journal’s managing editor, who told us that the authors had sought a retraction for the article, “An innovative noninvasive respiratory stress test indicates significant coronary artery disease,” in December, and that it had posted one on its website on Jan. 6 of this year. It will be in print in an upcoming issue.

The notice is not available on Medline, but it can be found on ScienceDirect: Continue reading More on SPIROCOR noninvasive heart disease test: Second retraction (in fact the first) says little